“…Although the data set did include frequency of visits and of debridements, additional data on treatment approaches for sickle cell ulcers-such as topical treatments, compression therapy, human skin equivalents, skin grafts, transfusion therapy, nutritional support, antibiot-ics, or pentoxifylline-were not available. 9,12 The analysis focused on healing within individual care episodes, and could not discern between wound recurrence and wound persistence. Finally, the analysis does not clarify to what degree larger area and longer duration at presentation are markers for intrinsically poorer healing processes in the patient, as opposed to markers of poor or delayed initiation of care that leads to worse healing prognosis.…”